The Effectiveness and Safety of TMF in the Treatment of Chronic Hepatitis B Patients With Normal ALT.
Status:
Recruiting
Trial end date:
2024-04-15
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, open, blank controlled trial ，in order to evaluate the
effectiveness and safety of Amibufenamide（TMF） in the treatment of chronic hepatitis B virus
infection patients with normal ALT at week 48.